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Potential gains in life expectancy by
reducing inequality of lifespans in
Denmark: an international comparison
and cause-of-death analysis
José Manuel Aburto1,2*† , Maarten Wensink1†, Alyson van Raalte2 and Rune Lindahl-Jacobsen1
Abstract
Background: Reducing lifespan inequality is increasingly recognized as a health policy objective. Whereas lifespan
inequality declined with rising longevity in most developed countries, Danish life expectancy stagnated between
1975 and 1995 for females and progressed slowly for males. It is unknown how Danish lifespan inequality changed,
which causes of death drove these developments, and where the opportunities for further improvements lie now.
Methods: We present an analytical strategy based on cause-by-age decompositions to simultaneously analyze changes
in Danish life expectancy and lifespan inequality from 1960 to 2014, as well as current Swedish-Danish differences.
Results: Stagnation in Danish life expectancy coincided with a shorter period of stagnation in lifespan inequality (1975–
1990). The stagnation in life expectancy was mainly driven by increases in cancer and non-infectious respiratory mortality
at higher ages (−.63 years) offsetting a reduction in cardiovascular and infant mortality (+ 1.52 years). Lifespan inequality
stagnated because most causes of death did not show compression over the time period. Both these observations were
consistent with higher smoking-related mortality in Danes born in 1919–1939. After 1995, life expectancy and lifespan
equality increased in lockstep, but still lag behind Sweden, mainly due to infant mortality and cancer.
Conclusions: Since 1960, Danish improvements in life expectancy and lifespan equality were halted by smoking-
related mortality in those born 1919–1939, while also reductions in old-age cardiovascular mortality held back lifespan
equality. The comparison with Sweden suggests that Denmark can reduce inequality in lifespans and increase life
expectancy through a consistent policy target: reducing cancer and infant mortality.
Keywords: Demography, Lifespan variability, Cancer, Mortality, Public health
Background
Life expectancy at birth is one of the most commonly
used measures of the health status of a population and
the performance of the healthcare system [1]. It repre-
sents the average age at death if everyone experienced
the prevailing death rates throughout their lifetime.
Another important dimension is the uncertainty around
that expectation (i.e. the variation in ages at death)
which is also known as lifespan inequality [2]. Lifespan
inequality has become relevant for policy makers with
the growing interest in economic and health inequalities,
[3, 4] in particular because: [1] it is a marker of hetero-
geneity in age at death at the macro level, and [2] it is a
marker of uncertainty in the timing of death at the mi-
cro level [5–7]. Typically, early deaths are more com-
mon in underprivileged groups, simultaneously reducing
life expectancy and increasing lifespan inequality [8–11].
Both indicators may have implications for individuals’
decisions over their life course. For instance, when to in-
vest in education or when to retire are decisions based
on life expectancy but also on the uncertainty surrounding
the eventual time of death [10].
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Life expectancy is lower in Denmark than in Norway
and Sweden for females and males. From 1975 to 1995,
while their Scandinavian counterparts showed continu-
ous improvement, life expectancy stagnated among
Danish women, while Danish men experienced only slow
progress. For both sexes, life expectancy improved after
1995, but remains lower than in Sweden and Norway
[12]. Differences between Denmark and Sweden in life
expectancy have been thoroughly documented [13, 14].
Among females, the stagnation in life expectancy re-
sulted mainly from the increased mortality of those born
from 1919 to 1939, cohorts with high levels of smoking
and alcohol consumption compared to their Swedish
contemporaries [13, 14]. Similarly, smoking-related mor-
tality was considerably higher in Danish compared to
Swedish males because of the widespread use of snus in-
stead of cigarettes in Sweden [15]. While these factors
are known contributors to life expectancy differences,
[16] their effects on lifespan inequality differences are un-
known. Previous evidence has shown mixed results for the
effects of smoking on lifespan inequality: little to no effect
on the Finnish population, [17] while it increased lifespan
inequality in some European countries [18].
The Danish case, juxtaposed with Sweden, is inter-
esting given the shared history, culture and similar-
ities in their healthcare systems [19]. It is unknown
how the different age and cause-of-death mortality
trends in the two countries would extend to lifespan
inequality patterns.
Because life expectancy and lifespan inequality tend to
be negatively correlated [5, 7] we hypothesize that 1)
during the last decades, Denmark experienced higher
lifespan inequality relative to Sweden in females and
males; 2) the 1975–1995 stagnation in life expectancy of
Danish women was accompanied by stagnation in life-
span inequality; 3) the slow increase in life expectancy
for males in the same period was accompanied by slow
reduction of lifespan inequality. Because it is
well-documented that smoking in the interwar Danish
female cohorts was a major cause of the 1975–1995
stagnation in Danish female life expectancy, [14] we
hypothesize that 4) any 1975–1995 stagnation in lifespan
inequality can be attributed to smoking-related deaths in
these cohorts.
Hence, we analyze data since 1960 for Denmark and
Sweden to make a cause-by-age analysis of changes in
life expectancy and lifespan inequality for both sexes.
Methods
Mortality and cause of death data
Period lifetables by sex and single year of age (0–110+)
were retrieved from the Human Mortality Database [12]
for Denmark and Sweden for the period 1960 to 2014.
Cause-of-death data were taken from the WHO Mortality
Database to compute the proportion of deaths by cause,
age, and sex in a given year [20]. Cause-of-death data are
available in 5-year age and single year categories. To
increase the accuracy of the resulting estimates, [21] causes
of death were ungrouped into single years of age using
efficient estimation of smooth distributions [22].
Cause-of-death classification
Data on causes of death were classified using the seventh,
eighth, ninth and tenth revisions of the International
Classification of Diseases (ICD) for the period studied
[23]. Deaths were grouped into seven major cause-of-death
categories aimed at capturing conditions that might have af-
fected mortality in these countries. We considered that
smoking prevalence was comparatively high among women
(and still remains higher) in Denmark; [14, 24] that the de-
crease in mortality from heart conditions (cardiovascular
revolution) took place during the studied period; [25] and
that the management of infectious diseases has improved
greatly over the past half century [26]. Hence, we grouped
causes of death up to age 84 as follows: 1) Cancers sensitive
to smoking, [27] 2) Cancers not sensitive to smoking, 3)
Cardiovascular diseases, 4) Non-infectious respiratory dis-
eases, 5) Infectious respiratory diseases, 6) External causes
and 7) Rest of causes. For ICD codes and details on the clas-
sification see Additional file 1: Table S1. Causes of death
above age 85 were not decomposed, because of lower reli-
ability in the presence of multi-morbidities [28]. Our group-
ings over the various ICD revisions were cross-checked to
be consistent with other coding practices across ICD ver-
sions in the literature [29]. We also checked for discontinu-
ities in death counts for each of the seven cause-of-death
groups over ICD transition years (Additional file 2:
Figure S2A and S2B). There were no major breaks at
years when ICD versions changed, indicating that cause-
specific mortality changes were real and not attributable
to inconsistencies in coding practice.
Lifespan inequality measure
Several dispersion measures have been proposed to
analyze lifespan inequality [30]. Here, we use the coeffi-
cient of variation (CoV), which is the standard deviation
divided by the mean of the lifetable age-at-death distri-
bution, i.e. life expectancy (A See Additional file 1,
Section 2 for a brief description). CoV has been found to
be a good indicator of lifespan inequality [31]. The
strong correlation between dispersion indicators sug-
gests that main conclusions and results would not differ
much between measures used [30, 32, 33]. Life expect-
ancy and lifespan inequality (CoV) were calculated for
Denmark and Sweden throughout 1960–2014.
A particular attribute of lifespan inequality indicators
is the threshold age that separates the ‘young-age com-
ponent’, also called premature mortality, from the ‘old-
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age component’ [8]. Saving lives at any age result in in-
creasing life expectancy. For lifespan inequality, improve-
ments below the threshold age decreases inequality, while
improvements above increase lifespan inequality.
Decomposition techniques
Cause-by-age decompositions of the changes in life
expectancy and lifespan inequality in Denmark and
Sweden were made from 1960 to 2014 using standard
decomposition techniques [34]. These decompositions
allow us to attribute the age and causes responsible for
changes in life expectancy or lifespan inequality between
any two periods, for instance between 1975 and 1995.1
We quantified the cause-by-age contributions to the
current differences in life expectancy and lifespan in-
equality between Denmark and Sweden for females
and males.
Results
Trends in lifespan inequality and life expectancy 1960–2014
The 1975–1995 stagnation in life expectancy for Danish
females was accompanied by a shorter period of stagna-
tion in lifespan inequality (Fig. 1a). Swedish females ex-
perienced a decrease in inequality and increase in life
expectancy throughout the period (Fig. 1a). For males in
both countries, life expectancy increase was slow in
1960–1980, but accelerated thereafter, while the decrease
in lifespan inequality was more monotonic (Fig. 1b).
Decomposition of changes in life expectancy and lifespan
inequality for Denmark
Between 1960 and 1975, Danish female life expectancy
increased from 74 to 77 years mainly due to reductions
in infant mortality and mid- and old-age cardiovascular
mortality (Fig. 2). For males1, infant mortality was also
reduced, but the contribution from cardiovascular dis-
eases was absent (see Additional file 3: Figure S1),
resulting in a small increase in life expectancy from
70.4 to 71.3 years. For both sexes, lifespan inequality
was reduced mainly because of the reduction in infant
mortality.
Between 1975 and 1995, Danish female life expectancy
stagnated at about 77 years because a continued reduction
in infant mortality and old-age cardiovascular mortality
was offset by an increase in (mainly smoking-related) can-
cer and non-infectious respiratory mortality between ages
55 and 85 (Fig. 2). Also, reduction in cardiovascular mor-
tality was lower in Danish females relative to Danish males
and Swedish females (Additional file 3: Figure S1). The
impact of mortality change on lifespan inequality is more
complicated due to the presence of the threshold age
described earlier: at younger ages mortality reduction re-
sults in deaths being compressed into a narrower age
range, reducing lifespan inequalities. At older ages mortality
reduction stretches out the right tail of the age-at-death
distribution, increasing lifespan inequality. Overall,
lifespan inequality was mostly unchanged among
Danish females because there was little compression
of mortality for most causes. Increases in smoking-re-
lated cancer and non-infectious respiratory diseases
were apparent over both these ‘younger’ and ‘older’
ages with opposite effects, but on balance increased
lifespan inequality during the period (Fig. 2). For
males, the reduction in lifespan inequality was larger
than for females, mainly driven by a reduction in infant
mortality and early-life external mortality (Additional file 3:
Figure S1).
Between 1995 and 2014, Danish female and male life
expectancy increased (from 77.8 to 82.7 and 72.7 to
78.6, respectively) due to almost all causes, particularly
cardiovascular conditions which occurred over adult
ages. As for lifespan inequality, for both sexes all ages
and all causes up to around the life expectancy reduced
inequality, while a reduction in cardiovascular mortality
at ages higher than life expectancy increased inequality.
Decomposition of current differences in life expectancy
and lifespan inequality between Denmark and Sweden
Currently (2014),2 life expectancy is higher in Sweden
than in Denmark for both sexes due to almost all causes
at all ages, with the major exception of external mortal-
ity being higher in Sweden than in Denmark at all ages,
in particular over ages 15–35 (Fig. 3). Two major classes
of mortality where Denmark is doing worse than
Sweden could be identified. First, infant mortality is
higher in Denmark than in Sweden (by a factor two).
Second, mid- and old-age cancer mortality is higher
in Denmark than in Sweden. Other recent years showed
the same pattern.
For lifespan inequality, the same holds: infant mortal-
ity and mid-life cancer mortality increase Denmark’s
disadvantage relative to Sweden, somewhat offset by
lower external mortality between ages 15 and 35 (Fig. 3).
However, Denmark’s life expectancy disadvantage relative
to Sweden is mainly due to mid- and high-age cancer
mortality, while Denmark’s lifespan inequality disadvan-
tage is mainly due to higher infant mortality (Fig. 3).
Potential gains in Danish life expectancy if lifespan
inequality were reduced towards Swedish levels
Reducing mortality from cancers below age 85 would
decrease the gap in lifespan inequality by 31 and 22% for
females and males, respectively (Table 1). This translates
into gains in life expectancy of 0.57 years for females
and 0.66 years for males, respectively 44 and 37% of the
overall life expectancy gap. Reducing infant mortality
(from all causes) to Swedish levels would reduce lifespan
inequality by 46% for females and 49% for males. This
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would be translated into gains in life expectancy of
.14 years for females and .16 years for males, respectively
10 and 9% of the total gap.
Achieving Swedish levels in cardiovascular conditions
would decrease the gap in lifespan inequality by almost
10% in both sexes and increase life expectancy by about
3 months. Conversely, if Sweden were to achieve the
level of Danish external mortality, it would benefit by
two additional months of life expectancy for both
sexes. Mortality above age 85 has negligible effect on
the difference between Denmark and Sweden in life-
span inequality.
Discussion
In this study, we found that the same causes and age
groups that held back Danish life expectancy in 1975–
1995, especially for females, also held back lifespan
equality in the same period. Although lifespan inequality
has declined and life expectancy has increased since the
late 1990s, Denmark still lags its Scandinavian counter-
parts, despite similarities in social and healthcare systems.
The comparison with Sweden suggests that Denmark can
now reduce inequality in lifespans and increase life expect-
ancy through the same policy targets: cancer and infant
mortality. This suggests an important social development,
but also a clear policy target.
Reducing lifespan inequality cannot be the only policy
goal, since this would neglect the interests of those who
have already lived to higher ages: The effect of mortality
reduction on lifespan inequality is large and negative at
age zero, decreases with increasing age, and reverses at a
unique threshold age, so that mortality reductions above
this threshold age increase lifespan inequality [5, 35].
Therefore, the causes that extend average lifespan and
the causes that reduce lifespan inequality are not neces-
sarily the same [36]. Smoking-related mortality is a clear
a
b
Fig. 1 Life expectancy (panel a) and lifespan inequality (panel b) trends from 1960 to 2014 for Denmark and Sweden by sex. The shaded area refers
to the period of life expectancy stagnation in Danish females 1975–1995
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example of this. In Denmark, life expectancy stagnated
over the 1975–1995 period because mortality reduction
from most causes of death was offset by mortality in-
crease from smoking-related causes. These increases in
smoking-related mortality had a smaller net impact on
lifespan inequality compared to life expectancy over the
same period, since smoking-related mortality occurred
both below and above the threshold age. By the latest
period 1995–2014, however, reduction in smoking-re-
lated mortality was comparatively more important for
decreases in lifespan inequality (19.4%) than increases in
life expectancy (11.2%). In general, the impact of smok-
ing on lifespan inequality is dependent on both the age
of smokers compared to non-smokers (the maturity of
the smoking epidemic), as well as the actual impact of
smoking on mortality at different ages [17]. Similar to
what was found in a comparison of G7 countries, [36]
reductions in injuries and child mortality were relatively
more important for lifespan inequality decrease than for
life expectancy increase.
In the 1975–1995 period, non-smoking cancers also
contributed (albeit to a small extent) to reductions in life
expectancy and increases in lifespan inequality. The con-
servative definition of smoking-related cancers in this
paper is one explanation for this phenomenon. Compet-
ing risks is another: people who previously died of other
causes could die of cancer, and these increased cancer
rates would show up as holding back life expectancy. In
a
b
Fig. 2 Age and cause contributions to changes in life expectancy (panel a) and lifespan inequality (panel b) between 1960 and 1975, 1975–1995
and 1995–2014 for Danish females. Note: Age 0 is truncated in panel B since it accounts for the largest contribution
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this respect, we note that non-smoking related cancer
was on the rise also in Sweden, so it is likely not a
phenomenon specific to Denmark. Specifically for Danish
females, other risk-taking behavior may have led to in-
creased cancer rates in general [13, 14].
Causes of death that drive within-country changes in
lifespan inequality are not necessarily the same as the
causes of death that drive contemporary gaps between
countries [37]. However, the comparison with Sweden
suggests that Denmark can simultaneous increase life
expectancy and decrease lifespan inequality by targeting
two main causes of death: cancer and infant mortality.
Reducing lifespan inequality towards Sweden by these
conditions would lead to an increase of 0.7 and 0.8 years
in life expectancy for females and males in Denmark, re-
spectively. To put this in perspective, in 2014 the infant
mortality rate in Denmark is twice as high as in Sweden,
which is one of the lowest among developed countries
[12]. Although mortality at very young ages may be af-
fected by different registration practices in high income
countries (e.g. non-viable live births registered as still-
births), [38] the Nordic countries do not show evidence
a
b
Fig. 3 Age and cause contributions to the gap in life expectancy (Panel a) and lifespan inequality (Panel b) with Sweden in 2014 by sex
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of such patterns [39]. Moreover, even after controlling
for gestational age Sweden showed lower infant mortality
rates than Denmark [40]. Thus, infant mortality is the lar-
gest single contributor to the gap with Sweden in terms of
lifespan inequality. Preventive policies focusing on pre-
natal risk factors and improving maternal health before
and during pregnancy, [41] as well as efforts to reduce the
risk of sudden infant death syndrome [42] could help to
reduce infant mortality towards Swedish levels.
Targeting cancer is another clear public health inter-
vention to reduce lifespan inequality and increase life ex-
pectancy in Denmark, confirming the priority given to
this objective for the last two decades through the
National Cancer Plans [43]. Our results show that im-
provements in cancer mortality have had an effect on
both health indicators over the last 20 years. However,
Denmark had the highest mortality rates from all neo-
plasms in the European region, and the female popula-
tion exhibited the highest lung cancer mortality rates
[24]. This is in line with our comparison with Sweden
and with previous evidence highlighting the role of
smoking behaviors on life expectancy trends [14].
For Sweden, the decomposition results suggest that
young-age external mortality can be further reduced.
According to the WHO, males in Denmark have lower
age-standardized external mortality rates (39 per
100,000) than Sweden and Norway (50.6 and 52 respect-
ively) in 2014 [44]. Our results further show that these
differences are concentrated between ages 15 and 40.
Moreover, since the late 1990s, Swedish and Norwegian
males have experienced higher suicide rates between
ages 15 and 24 [45].
The mere observation that Sweden is doing better
than Denmark for most causes of death does not mean
that Denmark could easily do better. However, it does
provide a starting point for public health intervention.
For instance, previous evidence suggests that focusing
on vulnerable and less socially advantaged subgroups
may reduce suicide rates among the young [45, 46].
For other countries that lag a comparable country,
similar decompositions can be made. This may not re-
sult in a clear and consistent message: causes of death
that hold back life expectancy may not be the same as
the causes of death that hold back equality. Yet if it does,
as in the case of Denmark when compared to Sweden,
the benefits are substantial, because the policy goals can
be so clearly stated. We therefore suggest that this
method could be a valuable tool for epidemiologists and
policy makers alike.
As any cause of death analysis, our study has the limi-
tations that: 1) causes of death are treated as mutually
exclusive, while they may not be (e.g., poor sight due to
diabetes may lead to an accident); 2) medical doctors
and even coroners have imperfect knowledge about
causes of death; and 3) trends in awareness of certain
diseases and changing insights in disease processes affect
classification. Yet through using otherwise high-quality
data and broad categories of causes of death, we believe
Table 1 Potential gains in life expectancy in Denmark if inequality is reduced (%) to Swedish levels in 2014 by cause of death
Sex Cause of death category and
mortality above age 85
Reduce gap with
Sweden in CoV (%)
Reduction in life
expectancy gap with Sweden (%)
Potential Gains in life
expectancy (years)
Females 1 Smoking-related cancer 18% 25% 0.35
2 Non-Smoking related cancer 13% 16% 0.22
3 Cardiovascular 10% 15% 0.21
4 Respiratory-Infectious 2% 2% 0.03
5 Respiratory-Non-infectious 7% 17% 0.23
6 External −26%a −11%b −0.15
7 Other 71% 40% 0.55
Above age 85 5% −3%b −0.05
Males 1 Smoking-related cancer 15% 26% 0.47
2 Non-Smoking related cancer 7% 10% 0.19
3 Cardiovascular 10% 19% 0.33
4 Respiratory-Infectious 1% 3% 0.05
5 Respiratory-Non-infectious 5% 7% 0.12
6 External −26%a −11%b −0.19
7 Other 92% 43% 0.77
Above age 85 0.0 0.0 0.04
aIncreases the gap with Sweden. Represents potential gains for Sweden if they achieve the levels of Denmark
bIncreases the gap with Sweden in life expectancy
Note: the sum of percentages differs from 100% due to rounding
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we have achieved a useful, workable grouping of causes
of death. In addition, we performed a sensitivity analysis
to assure consistency of grouping across ICD versions
and did not find significant variation when ICD revisions
changed (Additional file 2: Figure S2). In addition,
although the correlation between lifespan indicators
suggest that our results would not differ had we used a
different indicator, relative inequality indicators (e.g. co-
efficient of variation) differ in properties from indicators
that measure absolute lifespan inequality (e.g. standard
deviation). To alleviate any concern we replicated our
results using the standard deviation (Additional file 4:
Figure S3, Additional file 5: Figure S4, Additional file 6:
Figure S5, Additional file 7: Figure S6) and did not find
major differences.
Lifespan inequality is an important dimension of
population health. By looking at this dimension we could
disclose how lifespans differ within Denmark and
Sweden. Moreover, our decomposition by age and cause
of death allowed us to identify conditions and ages that
contribute the most to lifespan inequality changes, and
we were able to translate them into potential gains in life
expectancy if efforts were concentrated in these ages
and causes of death.
Conclusions
Lifespan inequality together with life expectancy gives a
broader perspective on the effect of mortality changes
on population health. Our results show that life expect-
ancy and lifespan inequality have been negatively corre-
lated since at least 1960 in Denmark. Currently,
Denmark lags Sweden both in terms of high life expect-
ancy and low inequality due to two main causes: infant
mortality and cancer. Denmark therefore has a clear and
consistent public health policy target: reduce infant mor-
tality and cancer mortality. Our approach demonstrates
how reduction in lifespan inequality as a policy target
can be translated into gains in life expectancy.
Endnotes
1We have created an interactive app where the reader
can analyze any period he/she might be interested in for
any sex. Available online app.
2Results for any year from 1960 to 2014 and for
Denmark vs Sweden available in online app.
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